Astellas Pharma Inc. et al v. Actavis Elizabeth LLC et al
Filing 515
[UNSEALED] REPORT AND RECOMMENDATION regarding supplemental claim construction issues. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 8/6/2019 and any responses due by 8/13/19.. Signed by Judge Christopher J. Burke on 7/30/2019.This order has been emailed to local counsel. (mlc) Modified on 8/1/2019 (mlc).
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
